Trials / Completed
CompletedNCT01491373
Pilot Study of rhBMP-2/ACS/LT-CAGE® for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
A Feasibility Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the feasibility of recombinant human bone morphogenetic protein-2 and absorbable collagen sponge with the tapered interbody fusion device (LT-CAGE® ) for anterior lumbar interbody fusion in patients with degenerative disc disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | rhBMP-2/ACS/LT-CAGE® Device | rhBMP-2/ACS inserted into Sofamor Danek's LT-CAGE® device. |
| DEVICE | Autograft/LT-CAGE® Device | LT-CAGE® device filled with autogenous bone taken from the patient's iliac crest |
Timeline
- Start date
- 1997-01-01
- Primary completion
- 1999-09-01
- Completion
- 1999-09-01
- First posted
- 2011-12-14
- Last updated
- 2013-08-02
Source: ClinicalTrials.gov record NCT01491373. Inclusion in this directory is not an endorsement.